Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels

The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet

(2008) V Di Marzo et al.   BRITISH JOURNAL OF PHARMACOLOGY

TRPV1 Receptors in the Central Nervous System: Potential for Previously Unforeseen Therapeutic Applications

(2008) Vincenzo Marzo et al.   CURRENT PHARMACEUTICAL DESIGN

Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese Patients: Pooled 1-year data from the Rimonabant in Obesity (RIO) program

(2008) L. Van Gaal et al.   DIABETES CARE

Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum

(2008) Mauro Maccarrone et al.   NATURE NEUROSCIENCE

FAAH and anandamide: is 2-AG really the odd one out?

(2008) Vincenzo Di Marzo et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST)

(2007) Gian Marco Leggio et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors

(2007) Fabricio A. Moreira et al.   NEUROPHARMACOLOGY

Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice

(2007) Nima Naderi et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR